Skip to content
2000
Volume 24, Issue 3
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Background

High-altitude cerebral edema (HACE) is a serious condition caused by prolonged hypobaric hypoxia (HH). Autophagic degradation of Claudin-5 plays a crucial role in HH-induced blood-brain barrier (BBB) damage. Hydroxychloroquine (HCQ), a lysosomal inhibitor used in autophagy treatment, reduces inflammation and BBB damage in traumatic brain injury. However, its effectiveness in preventing HACE is still unknown.

Methods

C57BL/6J mice were treated with HCQ and exposed to HH for 24 hrs to study BBB integrity. We evaluated BBB disruption brain water content, Evans blue, and FITC-dextran assays. Changes in tight junctions (TJs) of cerebrovascular endothelial cells were analyzed using electron microscopy and immunofluorescence. Western blotting quantified autophagy protein levels in brain tissue. Hypoxia-mimetic models were used to explore HCQ's effects on TJs and BBB permeability, confirmed by various assays, including immunofluorescence, electron microscopy, and Western blotting.

Results

HCQ significantly mitigated rapamycin-induced autophagy and Claudin-5 degradation. Prolonged hypoxia exposure promoted lysosomal degradation of Claudin-5, increasing endothelial cell permeability. HCQ inhibited autophagy in bEnd.3 cells the PI3K-Akt-mTOR and Erk pathway, reducing hypoxia-induced Claudin-5 down-regulation. In mice, HH exposure increased brain autophagy, damaging the vascular endothelial TJs and subsequently increasing endothelial permeability. Pretreatment with HCQ significantly reduced the level of autophagy in the brains of HH-exposed mice, thereby mitigating the HH-induced damage to vascular TJs, alleviating the downregulation of Claudin-5, and enhancing endothelial integrity.

Conclusion

HCQ effectively prevented HACE by inhibiting HH-induced Claudin-5 membrane expression downregulation, thus mitigating BBB damage and brain water content increase in HH-exposed mice.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X371235250417051313
2025-05-09
2026-02-26

  • From This Site

    /content/journals/cn/10.2174/011570159X371235250417051313
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GehnerJ. Altitude-related illness.Emerg. Med. Clin. North Am.202442352753910.1016/j.emc.2024.02.013 38925772
     [Google Scholar]
  2. DenormeF. PortierI. RustadJ.L. CodyM.J. de AraujoC.V. HokiC. AlexanderM.D. GrandhiR. DyerM.R. NealM.D. MajersikJ.J. YostC.C. CampbellR.A. Neutrophil extracellular traps regulate ischemic stroke brain injury.J. Clin. Invest.202213210e15422510.1172/JCI154225 35358095
     [Google Scholar]
  3. DehnertC. BärtschP. Acute mountain sickness and high-altitude cerebral edema.Ther. Umsch.2017741053554110.1024/0040‑5930/a000954 29690831
     [Google Scholar]
  4. LuksA.M. SwensonE.R. BärtschP. Acute high-altitude sickness.Eur. Respir. Rev.20172614316009610.1183/16000617.0096‑2016 28143879
     [Google Scholar]
  5. JensenJ.D. VincentA.L. High altitude cerebral edema.StatPearls2023
     [Google Scholar]
  6. EideC.P.T.R.P. AsplundC.A. Altitude illness.Curr. Sports Med. Rep.201211312413010.1249/JSR.0b013e3182563e7a 22580489
     [Google Scholar]
  7. UlrichS. LichtblauM. SchneiderS.R. SaxerS. BlochK.E. Clinician’s corner: Counseling patients with pulmonary vascular disease traveling to high altitude.High Alt Med. Biol.2022233ham.2022.0051.10.1089/ham.2022.0051 35852848
     [Google Scholar]
  8. AkselG. ÇorbacıoğluŞ.K. ÖzenC. High-altitude illness: Management approach.Turk. J. Emerg. Med.201919412112610.1016/j.tjem.2019.09.002 31687609
     [Google Scholar]
  9. LiY. ZhangY. ZhangY. Research advances in pathogenesis and prophylactic measures of acute high altitude illness.Respir. Med.201814514515210.1016/j.rmed.2018.11.004 30509704
     [Google Scholar]
  10. ReschkeM. SalvadorE. SchlegelN. BurekM. KarnatiS. WunderC. FörsterC.Y. Isosteviol sodium (STVNA) reduces pro-inflammatory cytokine IL-6 and GM-CSF in an in vitro murine stroke model of the blood–brain barrier (BBB).Pharmaceutics2022149175310.3390/pharmaceutics14091753 36145501
     [Google Scholar]
  11. ChoiC. KimH.M. ShonJ. ParkJ. KimH.T. KangS.H. OhS.H. KimN.K. KimO.J. The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model.Cytotherapy201820682082910.1016/j.jcyt.2018.04.004 29776835
     [Google Scholar]
  12. KawoosU. AbutarboushR. ZarrielloS. QadriA. AhlersS.T. McCarronR.M. ChavkoM. N-acetylcysteine amide ameliorates blast-induced changes in blood-brain barrier integrity in rats.Front. Neurol.20191065065110.3389/fneur.2019.00650 31297080
     [Google Scholar]
  13. HackettP.H. High altitude cerebral edema and acute mountain sickness. A pathophysiology update.Adv. Exp. Med. Biol.1999474234510.1007/978‑1‑4615‑4711‑2_2 10634991
     [Google Scholar]
  14. UrushidaY. KikuchiY. ShimizuC. AmariM. KawarabayashiT. NakamuraT. IkedaY. TakatamaM. ShojiM. Improved neuroimaging findings and cognitive function in a case of high-altitude cerebral edema.Intern. Med.20216081299130210.2169/internalmedicine.5747‑20 33229804
     [Google Scholar]
  15. TurnerR.E.F. GattererH. FallaM. LawleyJ.S. High-altitude cerebral edema: Its own entity or end-stage acute mountain sickness?J. Appl. Physiol.2021131131332510.1152/japplphysiol.00861.2019 33856254
     [Google Scholar]
  16. StokumJ.A. GerzanichV. SimardJ.M. Molecular pathophysiology of cerebral edema.J. Cereb. Blood Flow Metab.201636351353810.1177/0271678X15617172 26661240
     [Google Scholar]
  17. BoschM.M. MerzT.M. BarthelmesD. PetrigB.L. TrufferF. BlochK.E. TurkA. MaggioriniM. HessT. SchochO.D. HeftiU. SutterF.K.P. PichlerJ. HuberA. LandauK. New insights into ocular blood flow at very high altitudes.J. Appl. Physiol.2009106245446010.1152/japplphysiol.90904.2008 19057000
     [Google Scholar]
  18. XueY. WangX. WanB. WangD. LiM. ChengK. LuoQ. WangD. LuY. ZhuL. Caveolin-1 accelerates hypoxia-induced endothelial dysfunction in high-altitude cerebral edema.Cell Commun. Signal.202220116010.1186/s12964‑022‑00976‑3 36253854
     [Google Scholar]
  19. DeshwarA.R. CytrynbaumC. MurthyH. ZonJ. Variants in CLDN5 cause a syndrome characterized by seizures, microcephaly and brain calcifications.Brain202314662285229710.1093/brain/awac461 36477332
     [Google Scholar]
  20. YangZ. LinP. ChenB. ZhangX. XiaoW. WuS. HuangC. FengD. ZhangW. ZhangJ. Autophagy alleviates hypoxia-induced blood-brain barrier injury via regulation of CLDN5 (claudin 5).Autophagy202117103048306710.1080/15548627.2020.1851897 33280500
     [Google Scholar]
  21. QiaoN. AnZ. FuZ. ChenX. TongQ. ZhangY. RenH. Kinsenoside alleviates oxidative stress-induced blood-brain barrier dysfunction via promoting Nrf2/HO-1 pathway in ischemic stroke.Eur. J. Pharmacol.202394917571710.1016/j.ejphar.2023.175717 37054938
     [Google Scholar]
  22. GreeneC. HanleyN. ReschkeC.R. ReddyA. MäeM.A. ConnollyR. BehanC. O’KeeffeE. BolgerI. HudsonN. DelaneyC. FarrellM.A. O’BrienD.F. CryanJ. BrettF.M. BeausangA. BetsholtzC. HenshallD.C. DohertyC.P. CampbellM. Microvascular stabilization via blood-brain barrier regulation prevents seizure activity.Nat. Commun.2022131200310.1038/s41467‑022‑29657‑y 35422069
     [Google Scholar]
  23. TedeschiV. SapienzaS. CiancioR. CanzonieroL.M.T. PannaccioneA. SecondoA. Lysosomal channels as new molecular targets in the pharmacological therapy of neurodegenerative diseases via autophagy regulation.Curr. Neuropharmacol.202523437538510.2174/1570159X22666240517101846 38766825
     [Google Scholar]
  24. LeiZ.N. WuZ.X. DongS. YangD.H. ZhangL. KeZ. ZouC. ChenZ.S. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.Pharmacol. Ther.202021610767210.1016/j.pharmthera.2020.107672 32910933
     [Google Scholar]
  25. ZhaiJ. JiB. CaiL. LiuS. SunY. WangJ. Physiologically-based pharmacokinetics modeling for hydroxychloroquine as a treatment for malaria and optimized dosing regimens for different populations.J. Pers. Med.202212579610.3390/jpm12050796 35629219
     [Google Scholar]
  26. DimaA. JurcutC. ChassetF. FeltenR. ArnaudL. Hydroxychloroquine in systemic lupus erythematosus: Overview of current knowledge. Ther. Adv. Musculoskelet Dis.,2022141759720X21107300110.1177/1759720X211073001
     [Google Scholar]
  27. HusseinR.K. ElkhairH.M. Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19.J. Mol. Struct.2021123112997910.1016/j.molstruc.2021.129979 33518801
     [Google Scholar]
  28. FerreiraP.M.P. SousaR.W.R. FerreiraJ.R.O. MilitãoG.C.G. BezerraD.P. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms.Pharmacol. Res.202116810558210.1016/j.phrs.2021.105582 33775862
     [Google Scholar]
  29. HartmanO. KovanenP.T. LehtonenJ. EklundK.K. SinisaloJ. Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: Rationale and design of the OXI trial.Eur. Heart J. Cardiovasc. Pharmacother.201632pvw03510.1093/ehjcvp/pvw035 28025216
     [Google Scholar]
  30. DernoncourtA. HedhliK. AbisrorN. CheloufiM. CohenJ. KolanskaK. McAvoyC. SelleretL. BallotE. Mathieu d’ArgentE. ChabbertB.N. FainO. KayemG. MekinianA. Hydroxychloroquine in recurrent pregnancy loss: Data from a French prospective multicenter registry.Hum. Reprod.20243991934194110.1093/humrep/deae146 38942601
     [Google Scholar]
  31. HuJ. WangX. ChenX. FangY. ChenK. PengW. WangZ. GuoK. TanX. LiangF. LinL. XiongY. Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4/NF-κB signaling pathway.J. Neuroinflammation20221917110.1186/s12974‑022‑02430‑0 35346242
     [Google Scholar]
  32. SchrezenmeierE. DörnerT. Mechanisms of action of hydroxychloroquine and chloroquine: Implications for rheumatology.Nat. Rev. Rheumatol.202016315516610.1038/s41584‑020‑0372‑x 32034323
     [Google Scholar]
  33. McAfeeQ. ZhangZ. SamantaA. LeviS.M. MaX.H. PiaoS. LynchJ.P. UeharaT. SepulvedaA.R. DavisL.E. WinklerJ.D. AmaravadiR.K. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.Proc. Natl. Acad. Sci. USA2012109218253825810.1073/pnas.1118193109 22566612
     [Google Scholar]
  34. JiangX. GaoJ. FeiX. GengY. YueX. ShiZ. ChengX. ZhaoT. FanM. WuH. ZhaoM. ZhuL. Global profiling of protein lactylation in microglia in experimental high-altitude cerebral edema.Cell Commun. Signal.202422137410.1186/s12964‑024‑01748‑x 39054523
     [Google Scholar]
  35. LuY. ChangP. DingW. BianJ. WangD. WangX. LuoQ. WuX. ZhuL. Pharmacological inhibition of mitochondrial division attenuates simulated high-altitude exposure-induced cerebral edema in mice: Involvement of inhibition of the NF-κB signaling pathway in glial cells.Eur. J. Pharmacol.202292917513710.1016/j.ejphar.2022.175137 35793726
     [Google Scholar]
  36. ChenG. ChengK. NiuY. ZhuL. WangX. (−)-Epicatechin gallate prevents inflammatory response in hypoxia-activated microglia and cerebral edema by inhibiting NF-κB signaling.Arch. Biochem. Biophys.202272910939310.1016/j.abb.2022.109393 36084697
     [Google Scholar]
  37. WangX. ChenG. WanB. DongZ. XueY. LuoQ. WangD. LuY. ZhuL. NRF1-mediated microglial activation triggers high-altitude cerebral edema.J. Mol. Cell Biol.2022145mjac03610.1093/jmcb/mjac036 35704676
     [Google Scholar]
  38. LiuZ-L. ChenX-Y. SunZ-L. JiangX-F. ChengY-C. LiuY-F. YangK. ZhuS-L. KongX-B. TuY. BianK-F. Exendin-4 inhibits high-altitude cerebral edema by protecting against neurobiological dysfunction.Neural Regen. Res.201813465366310.4103/1673‑5374.230291 29722317
     [Google Scholar]
  39. WangX. XieY. NiuY. WanB. LuY. LuoQ. ZhuL. CX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting.Front. Cell. Neurosci.202317118934810.3389/fncel.2023.1189348 37234914
     [Google Scholar]
  40. SrinivasanB. KolliA.R. EschM.B. AbaciH.E. ShulerM.L. HickmanJ.J. TEER measurement techniques for in vitro barrier model systems.SLAS Technol.201520210712610.1177/2211068214561025 25586998
     [Google Scholar]
  41. RobinsonB.D. ShajiC.A. LomasA. TharakanB. Measurement of microvascular endothelial barrier dysfunction and hyperpermeability in vitro.Methods Mol. Biol.2018171723724210.1007/978‑1‑4939‑7526‑6_19 29468597
     [Google Scholar]
  42. TianW. AlsaadiR. GuoZ. KalininaA. CarrierM. TremblayM.E. LacosteB. LagaceD. RussellR.C. An antibody for analysis of autophagy induction.Nat. Methods202017223223910.1038/s41592‑019‑0661‑y 31768061
     [Google Scholar]
  43. ChenJ. ChenG. LiJ. QianC. MoH. GuC. YanF. YanW. WangL. Melatonin attenuates inflammatory response-induced brain edema in early brain injury following a subarachnoid hemorrhage: A possible role for the regulation of pro-inflammatory cytokines.J. Pineal Res.201457334034710.1111/jpi.12173 25187344
     [Google Scholar]
  44. ŞansaçarM. Gencer AkçokE.B. Measurement of autophagic activity in cancer cells with flow cytometric analysis using cyto-ID staining.Methods Mol. Biol.2024287921922410.1007/7651_2024_526 38446407
     [Google Scholar]
  45. Bernard-PatrzynskiF. LécuyerM.A. PuscasI. BoukhatemI. CharabatiM. BourbonnièreL. RamassamyC. LeclairG. PratA. RoullinV.G. Isolation of endothelial cells, pericytes and astrocytes from mouse brain.PLoS One20191412e022630210.1371/journal.pone.0226302 31851695
     [Google Scholar]
  46. KimY. LeeS. ZhangH. LeeS. KimH. KimY. WonM.H. KimY.M. KwonY.G. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.J. Neuroinflammation20201714810.1186/s12974‑020‑1727‑6 32019570
     [Google Scholar]
  47. ChunY. KimJ. AMPK–mTOR signaling and cellular adaptations in hypoxia.Int. J. Mol. Sci.20212218976510.3390/ijms22189765 34575924
     [Google Scholar]
  48. ChoiI. ZhangY. SeegobinS.P. PruvostM. WangQ. PurtellK. ZhangB. YueZ. Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration.Nat. Commun.2020111138610.1038/s41467‑020‑15119‑w 32170061
     [Google Scholar]
  49. DamriO. NaturS. AgamG. Do Autophagy enhancers/ROS scavengers alleviate consequences of mild mitochondrial dysfunction induced in neuronal-derived cells?Int. J. Mol. Sci.20212211575310.3390/ijms22115753 34072255
     [Google Scholar]
  50. NirkE.L. ReggioriF. MautheM. Hydroxychloroquine in rheumatic autoimmune disorders and beyond.EMBO Mol. Med.2020128e12476e110.15252/emmm.202012476 32715647
     [Google Scholar]
  51. HassanA.M.I.A. ZhaoY. ChenX. HeC. Blockage of autophagy for cancer therapy: A comprehensive review.Int. J. Mol. Sci.20242513745910.3390/ijms25137459 39000565
     [Google Scholar]
  52. BaiX. XiongJ. LiL. YuC. SunC. Suppression of hypoxia-induced CAV1 autophagic degradation enhances nanoalbumin-paclitaxel transcytosis and improves therapeutic activity in pancreatic cancer.Eur. J. Pharmacol.202496917643110.1016/j.ejphar.2024.176431 38395374
     [Google Scholar]
  53. BonamS.R. MullerS. BayryJ. KlionskyD.J. Autophagy as an emerging target for COVID-19: Lessons from an old friend, chloroquine.Autophagy202016122260226610.1080/15548627.2020.1779467 32522067
     [Google Scholar]
  54. AnN. ChenY. WangC. YangC. WuZ. XueJ. YeL. WangS. LiuH. PanQ. Chloroquine autophagic inhibition rebalances Th17/Treg-mediated immunity and ameliorates systemic lupus erythematosus.Cell. Physiol. Biochem.201744141242210.1159/000484955 29141242
     [Google Scholar]
  55. XuZ. HanX. OuD. LiuT. LiZ. JiangG. LiuJ. ZhangJ. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy.Appl. Microbiol. Biotechnol.2020104257558710.1007/s00253‑019‑10257‑8 31832711
     [Google Scholar]
  56. YuL. WeiJ. LiuP. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.Semin. Cancer Biol.202285699410.1016/j.semcancer.2021.06.019 34175443
     [Google Scholar]
  57. SunK. LuoJ. GuoJ. YaoX. JingX. GuoF. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: A narrative review.Osteoarthritis Cartilage202028440040910.1016/j.joca.2020.02.027 32081707
     [Google Scholar]
  58. SharmaA. MehanS. Targeting PI3K-AKT/mTOR signaling in the prevention of autism.Neurochem. Int.202114710506710.1016/j.neuint.2021.105067 33992742
     [Google Scholar]
  59. LiR. LinH. YeY. XiaoY. XuS. WangJ. WangC. ZouY. ShiM. LiangL. XuH. Attenuation of antimalarial agent hydroxychloroquine on TNF-α-induced endothelial inflammation.Int. Immunopharmacol.20186326126910.1016/j.intimp.2018.08.008 30121047
     [Google Scholar]
  60. WongS.K. Repurposing new use for old drug chloroquine against metabolic syndrome: A review on animal and human evidence.Int. J. Med. Sci.202118122673268810.7150/ijms.58147 34104100
     [Google Scholar]
  61. FengR. AdeniranS.O. HuangF. LiY. MaM. ZhengP. ZhangG. The ameliorative effect of melatonin on LPS-induced Sertoli cells inflammatory and tight junctions damage via suppression of the TLR4/MyD88/NF-κB signaling pathway in newborn calf.Theriogenology202217910311610.1016/j.theriogenology.2021.11.020 34871925
     [Google Scholar]
  62. DabrowskiW. Siwicka-GierobaD. KotfisK. ZaidS. TerpilowskaS. RobbaC. SiwickiA.K. The brain-gut axis-where are we now and how can we modulate these connections?Curr. Neuropharmacol.20211981164117710.2174/1570159X18666201119155535 33213347
     [Google Scholar]
  63. PersidskyY. HeilmanD. HaorahJ. ZelivyanskayaM. PersidskyR. WeberG.A. ShimokawaH. KaibuchiK. IkezuT. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE).Blood2006107124770478010.1182/blood‑2005‑11‑4721 16478881
     [Google Scholar]
  64. WuS. WangJ. LiuJ. ZhuH. LiR. WanX. LeiJ. LiY. YouC. HuF. ZhangS. ZhaoK. ShuK. LeiT. Programmed cell death 10 increased blood-brain barrier permeability through HMGB1/TLR4 mediated downregulation of endothelial ZO-1 in glioblastoma.Cell. Signal.202310711068310.1016/j.cellsig.2023.110683 37075875
     [Google Scholar]
  65. SwaminathanA. KasiviswanathanD. BalaguruU.M. KolluruG.K. SuryaKumar, G.; Chatterjee, S. Hypoxia perturbs endothelium by re-organizing cellular actin architecture: Nitric oxide offers limited protection.Tissue Cell20185011412410.1016/j.tice.2017.12.007 29429511
     [Google Scholar]
  66. JamiesonJ.J. LinY. MalloyN.A. SotoD. SearsonP.C. GerechtS. Hypoxia-induced blood-brain barrier dysfunction is prevented by pericyte-conditioned media via attenuated actomyosin contractility and claudin-5 stabilization.FASEB J.2022365e2233110.1096/fj.202200010RR 35476363
     [Google Scholar]
  67. AresG. BuonpaneC. SincavageJ. YuanC. WoodD.R. HunterC.J. Caveolin 1 is associated with upregulated claudin 2 in necrotizing enterocolitis.Sci. Rep.201991498210.1038/s41598‑019‑41442‑4 30899070
     [Google Scholar]
  68. KayyaliU.S. PennellaC.M. TrujilloC. VillaO. GaestelM. HassounP.M. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2.J. Biol. Chem.200227745425964260210.1074/jbc.M205863200 12202485
     [Google Scholar]
  69. HanY. YuanH. LiF. YuanY. ZhengX. ZhangX. SunJ. Ammidin ameliorates myocardial hypoxia/reoxygenation injury by inhibiting the ACSL4/AMPK/mTOR-mediated ferroptosis pathway.BMC Complement Med. Ther.202323145910.1186/s12906‑023‑04289‑x 38102654
     [Google Scholar]
  70. FanC. CaiW. YeM. ChenM. DaiY. Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro.J. Integr. Med.202220436537510.1016/j.joim.2022.04.005 35534381
     [Google Scholar]
  71. SunJ. YueF. Suppression of REDD1 attenuates oxygen glucose deprivation/reoxygenation-evoked ischemic injury in neuron by suppressing mTOR-mediated excessive autophagy.J. Cell. Biochem.20191209147711477910.1002/jcb.28737 31021470
     [Google Scholar]
  72. PreauS. DelgusteF. YuY. Remy-JouetI. RichardV. SaulnierF. BoulangerE. NeviereR. Endotoxemia engages the RhoA kinase pathway to impair cardiac function by altering cytoskeleton, mitochondrial fission, and autophagy.Antioxid. Redox Signal.2016241052954210.1089/ars.2015.6421 26602979
     [Google Scholar]
  73. HuberJ.D. EgletonR.D. DavisT.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier.Trends Neurosci.2001241271972510.1016/S0166‑2236(00)02004‑X 11718877
     [Google Scholar]
  74. MuradashviliN. KhundmiriS.J. TyagiR. GartungA. DeanW.L. LeeM.J. LominadzeD. Sphingolipids affect fibrinogen-induced caveolar transcytosis and cerebrovascular permeability.Am. J. Physiol. Cell Physiol.20143072C169C17910.1152/ajpcell.00305.2013 24829496
     [Google Scholar]
  75. CampbellM. HanrahanF. GobboO.L. KellyM.E. KiangA.S. HumphriesM.M. NguyenA.T.H. OzakiE. KeaneyJ. BlauC.W. KerskensC.M. CahalanS.D. CallananJ.J. WallaceE. GrantG.A. DohertyC.P. HumphriesP. Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury.Nat. Commun.20123184910.1038/ncomms1852 22617289
     [Google Scholar]
  76. YeZ.Y. XingH.Y. WangB. LiuM. LvP.Y. DL-3-n-butylphthalide protects the blood-brain barrier against ischemia/hypoxia injury via upregulation of tight junction proteins.Chin. Med. J.2019132111344135310.1097/CM9.0000000000000232 30939485
     [Google Scholar]
/content/journals/cn/10.2174/011570159X371235250417051313
Loading
Hydroxychloroquine Prevents High-altitude Cerebral Edema by Inhibiting Endothelial Claudin-5 Autophagic Degradation
Curr. Neuropharmacol. 24, 404 (2026); https://doi.org/10.2174/011570159X371235250417051313
/content/journals/cn/10.2174/011570159X371235250417051313
/content/journals/cn/10.2174/011570159X371235250417051313
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): autophagy; blood-brain barrier; Claudin-5; high-altitude cerebral edema; Hydroxychloroquine; prolonged hypobaric hypoxia

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test